Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GEORGINA LOYA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1912915158
CMS profile
86436
Location
HOUSTON, TX

General Payments · PY2018–2024

$3,399.41

  • Reported across 184 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$343.18

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $343.18 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $147.12 6
Amgen Inc. $90.82 5
Novo Nordisk AS $35.31 2
Astellas Pharma US Inc $24.39 1
Exact Sciences Corporation $23.82 1
PFIZER INC. $21.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $699.22 36
PY2019 $558.32 31
PY2020 $663.46 38
PY2021 $485.78 25
PY2022 $245.91 15
PY2023 $403.54 23
PY2024 $343.18 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $22.61 01/29/2024 Food and Beverage Undisputed 01/23/2026 1117314494 CMS
Amgen Inc. $19.16 04/01/2024 Food and Beverage Undisputed 01/23/2026 1117314496 CMS
Amgen Inc. $14.65 07/23/2024 Food and Beverage Undisputed 01/23/2026 1111638164 CMS
Amgen Inc. $19.69 10/16/2024 Food and Beverage Undisputed 01/23/2026 1111638166 CMS
Amgen Inc. $14.71 12/06/2024 Food and Beverage Undisputed 01/23/2026 1111638168 CMS
Astellas Pharma US Inc $24.39 09/30/2024 Food and Beverage Undisputed 01/23/2026 1139403309 CMS
Exact Sciences Corporation $23.82 08/13/2024 Food and Beverage Undisputed 01/23/2026 1114763985 CMS
Lilly USA, LLC $24.62 02/21/2024 Food and Beverage Undisputed 01/23/2026 1134986394 CMS
Lilly USA, LLC $16.77 03/04/2024 Food and Beverage Undisputed 01/23/2026 1134999650 CMS
Lilly USA, LLC $21.65 05/07/2024 Food and Beverage Undisputed 01/23/2026 1134987324 CMS
Lilly USA, LLC $32.03 08/20/2024 Food and Beverage Undisputed 01/23/2026 1134999652 CMS
Lilly USA, LLC $27.09 10/23/2024 Food and Beverage Undisputed 01/23/2026 1135006569 CMS
Lilly USA, LLC $24.96 11/19/2024 Food and Beverage Undisputed 01/23/2026 1134999476 CMS
Novo Nordisk Inc $17.34 02/27/2024 Food and Beverage Undisputed 01/23/2026 1097242808 CMS
Novo Nordisk Inc $17.97 05/13/2024 Food and Beverage Undisputed 01/23/2026 1096937127 CMS
PFIZER INC. $21.72 03/04/2024 Food and Beverage Undisputed 01/23/2026 1132028919 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.